BOSTON, May 23, 2024 (GLOBE NEWSWIRE) -- Aura Biosciences, Inc. (NASDAQ: AURA), a clinical-stage biotechnology company developing precision immunotherapies to treat solid tumors designed to preserve ...

An ocular migraine (retinal migraine) is a migraine that causes temporary vision loss in one eye. The term ocular migraine can also be used to describe migraine with aura. A migraine aura causes ...

For people diagnosed with ocular melanomas, the only effective treatment for many years has been radiation therapy which destroys sight in the affected eye. This was Melody Burchett’s experience when ...

A silent migraine, or acephalgic migraine, occurs without head pain, so getting a correct diagnosis from your doctor is important. Learn about symptoms and treatments.

An ocular migraine encompasses both retinal migraine, affecting one eye with temporary vision loss, and migraine with aura, which impacts both eyes and involves visual disturbances. A retinal migraine ...

No treatment-related serious adverse events were reported. Ocular treatment-related AEs were mild and resolved without sequelae. The safety profile of bel-sar was highly favorable in all participants ...

AURA has solid phase 2 data for a very interesting molecule in primary choroidal melanoma. This indication has no approved therapies, no major pipeline development, and many US/EU patients. AURA has ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Aura Biosciences Inc. (NASDAQ: AURA), a clinical-stage biotechnology company developing a novel class of virus-like drug conjugate (VDC) therapies for multiple ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Aura Biosciences Inc. (NASDAQ: AURA), a clinical-stage biotechnology company developing a novel class of virus-like drug conjugate (VDC) therapies for multiple ...